![]() Harbour Antibodies Harbour Antibodies uses transgenic mouse technology for engineering mice to produce high affinity human antibodies. | ![]() Rebiotix Rebiotix is a development-stage biotechnology company focusing on the treatment of GI diseases by developing human microbiome. | ![]() PDC Line Pharma PDC Line Pharma is a French-Belgium clinical-stage biotech company that develops a new class of active immunotherapies for cancer based on an allogeneic cell line of Plasmacytoid Dendritic cells (PDC*line) loaded with cancer antigens. | |||
Founding Date | Founding Date 2006 | Founding Date 2011 | Founding Date 2011 | Founding Date 2012 | Founding Date 2014 |
Type | Type Private | Type Private | Type Private | Type Private | Type Private |
Tags | |||||
Locations | Locations Newton, US HQ | Locations Redwood City, US HQ Baltimore, US | Locations Saint Paul, US HQ | Locations San Francisco, US HQ | Locations La Tronche, FR HQ Liège, BE |
Employees | Employees 1 | Employees 4 | Employees 70 | Employees 5 | Employees 375% decrease |
Funding | |||||
Latest funding round | Latest funding round $ 3.2m (almost 13 years ago) | Latest funding round $ 80m (almost 7 years ago) | Latest funding round $ 25m (almost 12 years ago) | Latest funding round $ 70m (over 7 years ago) | Latest funding round $ 22.2m (over 6 years ago) |
Total funding raised | Total funding raised $ 3.2m | Total funding raised $ 128.5m | Total funding raised $ 27.8m | Total funding raised $ 81.4m | Total funding raised $ 26.5m |

GrayBug is a biotechnology company developing technologies to treat eye diseases.
View company
Rebiotix is a development-stage biotechnology company focusing on the treatment of GI diseases by developing human microbiome.
View company
PellePharm, Inc. operates in the biotechnology industry.
View company
PDC Line Pharma is a French-Belgium clinical-stage biotech company that develops a new class of active immunotherapies for cancer based on an allogeneic cell line of Plasmacytoid Dendritic cells (PDC*line) loaded with cancer antigens.
View company